Patents by Inventor Jinan Peng

Jinan Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9174973
    Abstract: The present invention relates to the field of pharmaceutical chemistry. Disclosed herein is a crystalline form of azilsartan, which is substantially pure. The crystalline form is crystalline form A, form B, form C, form D, form E, form F, form G, form H, form I, form J or form K. The substantially pure crystalline forms of azilsartan of the invention generally have good properties such as high solubility, high bioavailability, good stability, long shelf life and good antistatic property. The crystalline forms of azilsartan generally exhibit an excellent performance in reducing clinical systolic blood pressure (SBP) and average 24-hour SBP. Disclosed herein are methods of preparing the substantially pure crystalline forms of azilsartan, pharmaceutical compositions comprising the crystalline forms, and preparation methods and uses thereof.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: November 3, 2015
    Assignees: SUNSHINE LAKE PHARMA CO., LTD., RUYUAN HEC PHARM CO., LTD.
    Inventors: Xin Lei, Jinan Peng, Tianming Wang, Zhiqing Lv, Wan Li
  • Publication number: 20140371279
    Abstract: The present invention relates to the field of pharmaceutical chemistry. Disclosed herein is a crystalline form of azilsartan, which is substantially pure. The crystalline form is crystalline form A, form B, form C, form D, form E, form F, form G, form H, form I, form J or form K. The substantially pure crystalline forms of azilsartan of the invention generally have good properties such as high solubility, high bioavailability, good stability, long shelf life and good antistatic property. The crystalline forms of azilsartan generally exhibit an excellent performance in reducing clinical systolic blood pressure (SBP) and average 24-hour SBP. Disclosed herein are methods of preparing the substantially pure crystalline forms of azilsartan, pharmaceutical compositions comprising the crystalline forms, and preparation methods and uses thereof.
    Type: Application
    Filed: September 27, 2012
    Publication date: December 18, 2014
    Applicants: SUNSHINE LAKE PHARMA CO., LTD., RUYUAN PHARM CO., LTD.
    Inventors: Xin Lei, Jinan Peng, Tianming Wang, Zhiqing Lv, Wan Li